Tanager Wealth Management’s Vivani Medical VANI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$753K Sell
607,276
-33,809
-5% -$40.9K 0.07% 74
2026
Q1
$641K Sell
641,085
-98,075
-13% -$123K 0.06% 72
2025
Q4
$909K Sell
739,160
-282,009
-28% -$408K 0.09% 57
2025
Q3
$1.44M Hold
1,021,169
0.15% 46
2025
Q2
$1.32M Sell
1,021,169
-202,654
-17% -$223K 0.16% 44
2025
Q1
$1.29M Hold
1,223,823
0.17% 39
2024
Q4
$1.42M Sell
1,223,823
-79,177
-6% -$100K 0.18% 36
2024
Q3
$1.52M Hold
1,303,000
0.21% 33
2024
Q2
$1.64M Hold
1,303,000
0.24% 33
2024
Q1
$2.41M Sell
1,303,000
-348,222
-21% -$513K 0.39% 31
2023
Q4
$1.68M Hold
1,651,222
0.31% 32
2023
Q3
$1.68M Hold
1,651,222
0.35% 31
2023
Q2
$2M Sell
1,651,222
-482,078
-23% -$594K 0.43% 32
2023
Q1
$2.13M Sell
2,133,300
-244,729
-10% -$272K 0.51% 31
2022
Q4
$2.02M Sell
2,378,029
-252,622
-10% -$411K 0.54% 30
2022
Q3
$6M Buy
+2,630,651
New +$12.5M 4.75% 7

Other funds holding VANI

Tanager Wealth Management's VANI Position: Q2 2026 in Review

Tanager Wealth Management reduced its Vivani Medical (VANI) stake by 5.3% in Q2 2026, selling an estimated $40.9K and leaving 607,276 shares worth $753K. The position accounts for 0.07% of the portfolio, ranked #74.

Tanager Wealth Management first reported a position in VANI in Q3 2022 and has held it in 16 quarters since. The position peaked at $6M in Q3 2022. 7 funds tracked by Wall St. Rank hold VANI as of Q2 2026.

  • Tanager Wealth Management held 607,276 shares of Vivani Medical worth $753K as of Q2 2026.
  • Tanager Wealth Management sold 33,809 Vivani Medical shares in Q2 2026, an estimated $40.9K.
  • Vivani Medical made up 0.07% of Tanager Wealth Management's portfolio in Q2 2026, its #74 holding.
  • Tanager Wealth Management first reported a position in Vivani Medical in Q3 2022 and has held it in 16 quarters since.
  • Tanager Wealth Management's Vivani Medical position peaked at $6M in Q3 2022.
  • 7 funds tracked by Wall St. Rank held Vivani Medical as of Q2 2026.

Based on Tanager Wealth Management's 13F filing for Q2 2026, filed 23 Jul 2026.